Publications by authors named "Steven R Alberts"

Claim this Profile
T
The Definition of Cure in Colon Cancer: A Pooled Analysis of 15 Randomized Clinical Trials.
Alessandro Pastorino, Heshan Liu, Levi Pederson, Valentino Martelli, Timothy Iveson, Steven R Alberts

JAMA Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, Elizabeth S Harlos, Matthew J Maurer, Steven R Alberts

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.
Hanla A Park, Dominic Edelmann, Federico Canzian, Petra Seibold, Tabitha A Harrison, Steven R Alberts

Int J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Sri Harsha Tella, Nathan Foster, Shi Qian, Tran Nguyen, Mitesh J Borad, Steven R Alberts

Oncologist· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer.
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, Charles S Fuchs, Ramesh K Ramanathan, Steven R Alberts

J Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200.
Bruce J Giantonio, Paul J Catalano, Neal J Meropol, Peter J O'Dwyer, Edith P Mitchell, Steven R Alberts

J Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Patrick McGarrah, Joleen Hubbard, Paul J Novotny, Megan E Branda, Daniel S Sargent, Steven R Alberts

Cancer Control· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.
Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy Iveson, Steven R Alberts

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis.
Hanla A Park, Dominic Edelmann, Federico Canzian, Tabitha A Harrison, Xinwei Hua, Steven R Alberts

Cancer Epidemiol Biomarkers Prev· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
Jennifer J Gile, Vanessa Wookey, Tyler J Zemla, Qian Shi, Zhaohui Jin, Steven R Alberts

Target Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.
Frank A Sinicrope, Qian Shi, Aurelie Catteau, Graham M Poage, Tyler J Zemla, Steven R Alberts

JCO Precis Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, Michael G Haddock, Shaker R Dakhil, Steven R Alberts

Oncologist· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trials.
Niki Christou, Elisabeth S Bergen, Clemence Canton, Karine Le Malicot, Maria Di Bartolomeo, Steven R Alberts

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience.
Jennifer J Gile, Fang-Shu Ou, Amit Mahipal, Joseph J Larson, Kabir Mody, Steven R Alberts

JCO Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
Jun Yin, Mohamed E Salem, Jesse G Dixon, Zhaohui Jin, Romain Cohen, Steven R Alberts

J Natl Cancer Inst· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).
Jai N Patel, Chen Jiang, Kouros Owzar, Flora Mulkey, Jasmine A Luzum, Steven R Alberts

Pharmacogenet Genomics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
Christopher Wills, Yazhou He, Matthew G Summers, Yi Lin, Amanda I Phipps, Steven R Alberts

Eur J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer.
Frank A Sinicrope, Qian Shi, Thomas C Smyrk, Richard M Goldberg, Steven J Cohen, Steven R Alberts

JNCI Cancer Spectr· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study.
Xinwei Hua, James Y Dai, Sara Lindström, Tabitha A Harrison, Yi Lin, Steven R Alberts

Cancer Epidemiol Biomarkers Prev· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).
Harry H Yoon, Fang-Shu Ou, Gamini S Soori, Qian Shi, Dennis A Wigle, Steven R Alberts

Eur J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
Anna D Wagner, Axel Grothey, Thierry Andre, Jesse G Dixon, Norman Wolmark, Steven R Alberts

J Natl Cancer Inst· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Predictors of Severe Skin Toxicity in Patients with Stage III Colon Cancer Treated with Cetuximab: NCCTG N0147 (Alliance).
Julia D Labadie, Xinwei Hua, Tabitha A Harrison, Barbara L Banbury, Jeroen R Huyghe, Steven R Alberts

Cancer Epidemiol Biomarkers Prev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.
Edoardo Francini, Fang-Shu Ou, Stefano Lazzi, Roberto Petrioli, Andrea G Multari, Steven R Alberts

Transl Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials.
Frank A Sinicrope, Sakti Chakrabarti, Pierre Laurent-Puig, Luke Huebner, Thomas C Smyrk, Steven R Alberts

Eur J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.
Aziz Zaanan, Qian Shi, Julien Taieb, Steven R Alberts, Jeffrey P Meyers

JCO Precis Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis